Listen

Description

What does Avulux’s FDA De Novo classification mean for private practice optometry?

In this episode, Dr. Charles Posternack, CEO of Avulux, joins Scott to explain the milestone and what it means for independent practices. They discuss who Avulux is indicated for, the potential impact on optical revenue and capture rate, what implementation looks like, and how practices can get started. 

Learn why Avulux partnered with Acquios Alliance and how the relationship supports private practice optometrists! 

To connect with Avulux, reach out to us at info@acquiosalliance.com!